Avance Biosciences is pleased to announce that we will be exhibiting at Festival of Biologics USA 2026, taking place March 4–5, 2026, at the San Diego Convention Center. You can find our team at Booth #322.
Festival of Biologics USA is a leading industry event bringing together scientists, developers, and decision-makers working across biologics, immunotherapies, cell and gene therapies, and emerging therapeutic modalities. The conference provides a valuable forum for discussing innovation across the biologics development lifecycle—from discovery and translational research to manufacturing and commercialization.
At the event, Avance Biosciences will highlight our CGMP-, GLP-, and CLIA-compliant analytical and bioanalytical services supporting biologic drug development, including monoclonal antibodies, bispecifics, ADCs, and emerging protein-based therapeutics. Our capabilities span assay development and validation, potency and functional bioassays, immunogenicity testing, pharmacokinetic and biomarker analysis, and biologics quality control, providing regulatory-ready data from early development through commercial manufacturing
Our team looks forward to connecting with biotech, pharmaceutical, and CDMO partners to discuss how Avance’s scientific expertise, regulatory-ready quality systems, and evolving technology platforms can help advance complex biologic programs with confidence.
If you plan to attend Festival of Biologics USA 2026, we invite you to stop by Booth #322 to meet our team and learn more about how Avance Biosciences supports the development of next-generation therapies.
When you partner with Avance Biosciences™, you gain a CRO partner that is creative, collaborative and dedicated to sound science with a focus on the regulatory requirements our partners require. Contact our technical staff to discuss how we can support you in your project!
